Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Amgen
Institute of Hematology & Blood Diseases Hospital, China
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Washington
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Nantes University Hospital
Children's Hospital of Philadelphia
St. Jude Children's Research Hospital
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Aarhus University Hospital
Comenius University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Nice
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Wake Forest University Health Sciences
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Florida
Princess Maxima Center for Pediatric Oncology
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Janssen Research & Development, LLC
Washington University School of Medicine
Murdoch Childrens Research Institute
University of Miami
Children's Oncology Group
PedAL BCU, LLC
Children's Oncology Group
TScan Therapeutics, Inc.
Gilead Sciences
University of Rochester